FDA Approves New Antidepressant


The drug Brintellix has been approved to treat depression, the U.S. Food and Drug Administration announced Monday.

“Major depressive disorder can be disabling and can keep a person from functioning normally,” Dr. Mitchell Mathis, acting director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research, said in a news release. “Since medications affect everyone differently, it is important to have a variety of treatment options available for patients who suffer from depression.”

via Health Highlights: Oct. 1, 2013.